Vivos Therapeutics
VVOS----
Vivos Therapeutics (VVOS)
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients wit...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Vivos Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 8, 2026Price forecast
$2.12438.46%
Forecast & RatingBuy
3analysts
- Strong buy66.67%
- Buy0.00%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 22 at 02:46 PM
Vivos President Brad Weeks acquires $4,600 of common shares
- TradingView · Jul 15 at 04:16 PM
Michael C. Skaff Discloses Investment at Vivos Therapeutics with 19.9% Stake
- PUBT · Jul 15 at 03:23 PM
Vivos Therapeutics discloses V-Co Investors 4 as beneficial owner in Form 3 filing
- Tip Ranks · Jul 7 at 04:47 PM
Vivos Therapeutics Creates New Series A Preferred Stock
- TradingView · Jul 7 at 04:33 PM
Vivos Therapeutics Raises $2.1 Million in PIPE With V-Co 4 and Bigger Capital
- PUBT · Jul 7 at 04:30 PM
Vivos Therapeutics files registration statement for PIPE warrant, conversion share resales
